Evaluation of safety of a newly formulated pirfenidone in chronic kidney disease: A non-randomized pilot study in mexican patients

Category Primary study
JournalJournal of Renal and Hepatic Disorders
Year 2020
This article has no abstract
Epistemonikos ID: 9bfb12e95af9d121c3af06f90636a4042b0e7e59
First added on: Feb 12, 2025